Clinically Speaking: Boosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read MoreClinically Speaking: Behavioral Health Services in America
92% of adults living with a behavioral health condition also struggle with a physical condition, costing billions annually. We detail strategies to overcome the barriers that keep individuals from see...
Read MoreClinically Speaking: Preventive Care and Wellness
Preventive care has many facets but the cornerstone is wellness screenings, which can help providers catch cancer and chronic disease early when it is easier and less costly to treat.
Read MoreClinically Speaking: Encouraging Members to Prioritize Personal Health
We explore actions plan sponsors can take to encourage members and employees to make their health a priority.
Read MoreClinically Speaking: Gene Therapies: Million-Dollar Miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read MoreClinically Speaking: Cardiodiabesity 101
More than half of U.S. adults suffer from cardiovascular disease, diabetes or obesity and a growing number experience all three. Plan sponsors can take action to address this increasingly complex chal...
Read MoreClinically Speaking: The Health Care Total Cost of Musculoskeletal Conditions
Musculoskeletal conditions affect more than 1 in 2 adults and cost our health care system an estimated $420 billion—more than any other chronic condition.
Read MoreThe Pharmacy Benefit Management Team: Helping Patients Access Affordable Prescription Drugs Safely and Efficiently
Pharmacy benefit managers (PBMs) like Express Scripts are uniquely positioned to help patients in numerous ways.
Read More